Department of Medicine, Division (Krannert Institute) of Cardiology, Indiana University, Indianapolis, IN 46202, USA.
Am Heart J. 2010 Dec;160(6):1137-41, 1141.e1. doi: 10.1016/j.ahj.2010.07.032.
Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1.
History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients.
Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P=.001) and QRS duration≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P<.001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P<.001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P<.001).
A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.
1 型肌强直性营养不良(DM1)是一种神经系统疾病,已知其与心脏受累有关,包括左心室收缩功能障碍(LVSD)、心力衰竭(HF)、房室和室内传导系统疾病以及心源性猝死。我们研究了大量 DM1 患者中这些疾病的患病率以及相关发现。
对 406 例 DM1 患者进行了病史、体格检查、基因检测和心电图检查,其中 180 例(44.3%)患者进行了心脏成像检查。
LVSD 和临床 HF 在 180 例患者中的 34 例(18.9%)和 406 例患者中的 23 例(5.7%)中发现,406 例患者的总体 LVSD/HF 患病率为 41(10.1%)。年龄增长、男性、心电图传导异常、存在房性和室性心律失常以及植入设备均与 LVSD/HF 显著相关,而胞嘧啶-胸腺嘧啶-鸟嘌呤重复序列长度和神经肌肉严重程度评分则没有。间隔时间≥240 毫秒(相对风险 4.1,95%置信区间 1.7-9.6,P=.001)和 QRS 持续时间≥120 毫秒(相对风险 4.2,95%置信区间 2.0-8.5,P<.001)是 LVSD/HF 的显著预测因子。LVSD/HF 的存在也与全因死亡(相对风险 3.9,95%置信区间 2.3-6.4,P<.001)和心脏性死亡(相对风险 5.7,95%置信区间 2.6-12.4,P<.001)显著相关。
DM1 患者中存在显著的 LVSD/HF 患病率。LVSD/HF 的存在与 DM1 患者的全因和心脏死亡显著相关。